The global pain management market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic pain, rising geriatric population, and growing awareness about the benefits of pain management. Pharmaceuticals segment accounted for the largest share in the global pain management market in 2018 and is expected to continue its dominance throughout the forecast period. The pharmaceuticals segment includes drugs that are used for treating acute or chronic pain conditions such as opioids, non-steroidal anti-inflammatory drugs (NSAIDs), antidepressants, anticonvulsants, and others. These drugs are prescribed by physicians based on their efficacy and side effects profile. North America dominated the global pharmaceuticals segment in 2018 with a share of over 40%. This can be attributed to high prevalence rates of chronic diseases such as cancer and diabetes among adults in North America which leads to increased incidence rates of various types of pains including neuropathic pains which require long-term treatment with analgesics or other medications that have been approved by regulatory authorities for this purpose.
Some Of The Growth Factors Of This Market:
- The aging population is a major factor in the growth of the pain management market.
- The increase in chronic pain cases is also a major factor in the growth of the pain management market.
- The increasing number of people suffering from chronic diseases such as cancer, diabetes, and arthritis are also factors that contribute to the growth of this market.
- Increasing awareness about pain management and its benefits among patients is another factor that contributes to this market's growth.
- Increasing research on new drugs for treating chronic conditions such as cancer, diabetes, and arthritis will also contribute to this market's growth.
Industry Growth Insights published a new data on “Pain Management Market”. The research report is titled “Pain Management Market research by Types (Pharmaceuticals, Devices), By Applications (Burn Pain, Cancer Pain, Dental/Facial Pain, Migraine Headache Pain, Musculoskeletal Pain, Neuropathic Pain, Obstetrical Pain), By Players/Companies Abbvie Inc., Astrazeneca Depomed Inc., Djo Global Inc., Eli Lilly & Co., Endo International, Glaxosmithkline, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson, Medtronic Inc., Novartis International Ag, Pfizer, Purdue Pharmaceuticals Lp, St. Jude Medical Inc.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pain Management Market Research Report
By Type
Pharmaceuticals, Devices
By Application
Burn Pain, Cancer Pain, Dental/Facial Pain, Migraine Headache Pain, Musculoskeletal Pain, Neuropathic Pain, Obstetrical Pain
By Companies
Abbvie Inc., Astrazeneca Depomed Inc., Djo Global Inc., Eli Lilly & Co., Endo International, Glaxosmithkline, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson, Medtronic Inc., Novartis International Ag, Pfizer, Purdue Pharmaceuticals Lp, St. Jude Medical Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Pain Management Market Report Segments:
The global Pain Management market is segmented on the basis of:
Types
Pharmaceuticals, Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Burn Pain, Cancer Pain, Dental/Facial Pain, Migraine Headache Pain, Musculoskeletal Pain, Neuropathic Pain, Obstetrical Pain
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbvie Inc.
- Astrazeneca Depomed Inc.
- Djo Global Inc.
- Eli Lilly & Co.
- Endo International
- Glaxosmithkline
- Hisamitsu Pharmaceutical Co. Inc.
- Johnson & Johnson
- Medtronic Inc.
- Novartis International Ag
- Pfizer
- Purdue Pharmaceuticals Lp
- St. Jude Medical Inc.
Highlights of The Pain Management Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pharmaceuticals
- Devices
- By Application:
- Burn Pain
- Cancer Pain
- Dental/Facial Pain
- Migraine Headache Pain
- Musculoskeletal Pain
- Neuropathic Pain
- Obstetrical Pain
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pain Management Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pain management is the process of managing pain in a person. Pain can be physical, emotional, or both. Pain management may include treatments such as medication, surgery, and physical therapy.
Some of the key players operating in the pain management market are Abbvie Inc., Astrazeneca Depomed Inc., Djo Global Inc., Eli Lilly & Co., Endo International, Glaxosmithkline, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson, Medtronic Inc., Novartis International Ag, Pfizer, Purdue Pharmaceuticals Lp, St. Jude Medical Inc..
The pain management market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pain Management Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pain Management Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pain Management Market - Supply Chain
4.5. Global Pain Management Market Forecast
4.5.1. Pain Management Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pain Management Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pain Management Market Absolute $ Opportunity
5. Global Pain Management Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pain Management Market Size and Volume Forecast by Type
5.3.1. Pharmaceuticals
5.3.2. Devices
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pain Management Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pain Management Market Size and Volume Forecast by Application
6.3.1. Burn Pain
6.3.2. Cancer Pain
6.3.3. Dental/Facial Pain
6.3.4. Migraine Headache Pain
6.3.5. Musculoskeletal Pain
6.3.6. Neuropathic Pain
6.3.7. Obstetrical Pain
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pain Management Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pain Management Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pain Management Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pain Management Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pain Management Demand Share Forecast, 2019-2029
9. North America Pain Management Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pain Management Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pain Management Market Size and Volume Forecast by Application
9.4.1. Burn Pain
9.4.2. Cancer Pain
9.4.3. Dental/Facial Pain
9.4.4. Migraine Headache Pain
9.4.5. Musculoskeletal Pain
9.4.6. Neuropathic Pain
9.4.7. Obstetrical Pain
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pain Management Market Size and Volume Forecast by Type
9.7.1. Pharmaceuticals
9.7.2. Devices
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pain Management Demand Share Forecast, 2019-2029
10. Latin America Pain Management Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pain Management Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pain Management Market Size and Volume Forecast by Application
10.4.1. Burn Pain
10.4.2. Cancer Pain
10.4.3. Dental/Facial Pain
10.4.4. Migraine Headache Pain
10.4.5. Musculoskeletal Pain
10.4.6. Neuropathic Pain
10.4.7. Obstetrical Pain
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pain Management Market Size and Volume Forecast by Type
10.7.1. Pharmaceuticals
10.7.2. Devices
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pain Management Demand Share Forecast, 2019-2029
11. Europe Pain Management Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pain Management Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pain Management Market Size and Volume Forecast by Application
11.4.1. Burn Pain
11.4.2. Cancer Pain
11.4.3. Dental/Facial Pain
11.4.4. Migraine Headache Pain
11.4.5. Musculoskeletal Pain
11.4.6. Neuropathic Pain
11.4.7. Obstetrical Pain
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pain Management Market Size and Volume Forecast by Type
11.7.1. Pharmaceuticals
11.7.2. Devices
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Yo-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pain Management Demand Share, 2019-2029
12. Asia Pacific Pain Management Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pain Management Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pain Management Market Size and Volume Forecast by Application
12.4.1. Burn Pain
12.4.2. Cancer Pain
12.4.3. Dental/Facial Pain
12.4.4. Migraine Headache Pain
12.4.5. Musculoskeletal Pain
12.4.6. Neuropathic Pain
12.4.7. Obstetrical Pain
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pain Management Market Size and Volume Forecast by Type
12.7.1. Pharmaceuticals
12.7.2. Devices
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pain Management Demand Share, 2019-2029
13. Middle East & Africa Pain Management Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pain Management Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pain Management Market Size and Volume Forecast by Application
13.4.1. Burn Pain
13.4.2. Cancer Pain
13.4.3. Dental/Facial Pain
13.4.4. Migraine Headache Pain
13.4.5. Musculoskeletal Pain
13.4.6. Neuropathic Pain
13.4.7. Obstetrical Pain
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pain Management Market Size and Volume Forecast by Type
13.7.1. Pharmaceuticals
13.7.2. Devices
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pain Management Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Pain Management Market: Market Share Analysis
14.2. Pain Management Distributors and Customers
14.3. Pain Management Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbvie Inc.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Astrazeneca Depomed Inc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Djo Global Inc.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Eli Lilly & Co.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Endo International
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Glaxosmithkline
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Hisamitsu Pharmaceutical Co. Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Johnson & Johnson
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Medtronic Inc.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Novartis International Ag
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Pfizer
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Purdue Pharmaceuticals Lp
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. St. Jude Medical Inc.
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook